American tech executive and Oura Health CEO
Oura has postponed its U.S. IPO plan, citing uncertainty in the IPO market. The health-tech ring maker had aimed to raise up to $2.2 billion and list on Nasdaq. Executives say the move reflects current macro headwinds, including rising bond yields and AI spending concerns.